| 
| Webinar: A Systems Model of Gene Therapy for Sickle Cell Disease Tuesday, November 30 | 2pm ET / 11am PT Stem cell gene therapy is an emerging experimental therapy for SCD with the potential for lifelong cure but it is an expensive multi-step treatment regimen. This webinar is ideal for scientists and decision makers in drug R&D who want to leverage systems pharmacology for drug discovery and development. Register Now. |
Featured Story | By Ben Adams GlaxoSmithKline is making its first major foray into treating the fatty liver condition known as NASH as it pens a $1 billion asset pact with Arrowhead Pharmaceuticals. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Five years late and 200% over budget, AstraZeneca has finally formally unveiled the Cambridge, U.K., site that is at the heart of its R&D strategy. read more By Annalee Armstrong Reshma Shetty is part of a trend of founder-led biotechs that have risen in prominence in recent years, going from startup to well known with lightning speed. These scientists-turned C-suite occupants know their technology inside out. They’ve got credibility both at the bench working with their research teams and in the boardrooms selling their future products. read more Sponsored By: New Product Planning Summit Join us in person on December 1-2 in Boston, MA to become a part of this growing community of eager professionals who are navigating the New Product Planning space during these uncertain times. read more By Ben Adams Norwegian vaccine and immunotherapy biotech Vaccibody has changed its name to Nykode Therapeutics to “signify a new phase of growth and development,” and it started that phase with more than just PR speak. read more By Nick Paul Taylor Rafael Holdings is clearing out its C-suite. Weeks after the failure of its lead cancer drug, Rafael has disclosed the planned departures of five executives as it adapts to life without a near-approval asset. read more By Andrea Park Racial and gender biases in medical devices are "totally unacceptable," said Sajid Javid, the U.K.’s secretary of state for health and social care. read more By Kevin Dunleavy Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase Novartis' generics unit Sandoz for $21.6 billion, according to German newspaper Handelsblatt. The price would make it the largest pharma deal of the year. read more By Robert King A Bloomberg survey of 25 major insurers found that none of the payers believe it's medically necessary to cover a controversial Alzheimer's drug made by Biogen. read more Resources Sponsored by: Medable, Inc. Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper. Sponsored by: Thermo Fisher Scientific A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants. Sponsored by: IQVIA Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making. Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Blue Matter Consulting Paper describing how the chronic insomnia market offers big lessons for any biopharma company thinking about getting into digital therapeutics in any therapeutic area. Sponsored by: TransPerfect Life Sciences Every detail is important when selecting a new eCOA solution; learn more about the current eCOA landscape, best practices, and crucial considerations for successful eCOA solution deployment in this white paper. Sponsored by: Informa Pharma Intelligence and Oracle Health Sciences New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic. Sponsored by: Thermo Fisher Scientific Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific Sponsored by: Thermo Fisher Scientific Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Fierce New Product Planning Summit December 1-2, 2021 | Boston, MA Fierce Launch Readiness for Medical Affairs & Communications Teams December 1-2, 2021 | Boston, MA Learn how therapeutics are successfully launched and commercialized December 1-2, 2021 | Live & Online 2nd Annual Symposium on Translational Medicine and Biomanufacturing December 2—3, 2021 Fierce Virtual Clinical Trials Summit December 6-7, 2021 | Philadelphia, PA Fierce JPM Week 2022 January 11, 2022 | San Francisco, CA
January 18-20, 2022 | Virtual Event Virtual European Healthcare Compliance Certificate Program January 24-28, 2022 Fierce Drug Safety Summit February 8-9, 2022 | Arlington, VA Fierce Business Development and Licensing Summit March 2022 | San Francisco, CA Fierce Medical Affairs Strategic Summit (MASS) East April 2022 | New Jersey Fierce Health IT Summit April 20, 2022 | Virtual Event Fierce Trial Master File Summit May 2022 | Location TBD Fierce Promotional Review Committee Compliance and Best Practices Summit April 2022 | New Jersey Fierce Digital Pharma Innovation Week June 2022 | Virtual Event Fierce Biotech Next-Gen June 29, 2022 | Virtual Event Fierce Pharma PR & Communications Summit July 2022 | Location TBD (NYC Metro Area) Fierce Biotech Forum October 2022 | Location TBD Fierce Biotech Virtual Forum October 19, 2022 | Virtual Event | 
